Single Lung Transplant vs Double Lung Transplant: A Single-Center Experience With Particular Consideration for Idiopathic Pulmonary Arterial Hypertension

• Published in: Transplantation proceedings 2020-09, Vol.52 (7), p.2138-2142
• Main Authors: Antończyk, Remigiusz, Stącel, Tomasz, Urlik, Maciej, Latos, Magdalena, Kręt, Michał, Borowik, Dawid, Wajda-Pokrontka, Marta, Zawadzki, Fryderyk, Tatoj, Zofia, Przybyłowski, Piotr, Zembala, Marian, Ochman, Marek, Nęcki, Mirosław
• Format: Article
• Language: English
• Subjects: Adult; Cystic Fibrosis - surgery; Familial Primary Pulmonary Hypertension - surgery; Female; Humans; Lung Transplantation - methods; Lung Transplantation - mortality; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive - surgery; Retrospective Studies; Treatment Outcome
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2020.03.046

Lung transplant remains the only viable treatment for certain patients with end-stage lung diseases. Such patients can become either single or double lung recipients. The 2 procedures are associated with specific risks and benefits. The aim of the study was to assess the survival of patients after lung transplant in a single center. The retrospective study consists of 128 lung transplant recipients. Patients underwent transplant between 2004 and 2017 because of following diseases: chronic obstructive pulmonary disease (28.2%), cystic fibrosis (26.5%), and primary pulmonary hypertension (12.3%), including idiopathic pulmonary arterial hypertension and interstitial lung diseases (33%). Patients with idiopathic pulmonary arterial hypertension were not treated with postoperative extracorporeal membrane oxygenation as left heart conditioning. Regardless of underlying disease, 75% of DLT recipients and 51% of SLT recipients reached 5-year survival (P = .0066). A total of 87% of lung transplant recipients with cystic fibrosis reached 1-year survival. Among lung recipients with primary pulmonary hypertension who underwent DLT and SLT, 5-year survival was reached by 84% and 51%, respectively (P = .025). Among patients with chronic obstructive pulmonary disease, 82% of DLT recipients and 62% of SLT recipients reached 1-year survival (P = .22). Patients who received transplants because of primary pulmonary hypertension presented the worst short-term survival among all SLT recipients. Patients with CF have the best overall survival among all lung transplant recipients. Double lung transplant provides statistically significantly better outcomes than single lung transplant. This observation is also present among recipients who underwent transplant because of primary pulmonary hypertension, as single lung transplant is not recommended among such patients in particular. •Patients with cystic fibrosis have the best overall survival among all lung transplant recipients.•Double lung transplant provides statistically significantly better outcomes than single lung transplant.•This observation is also present among recipients who underwent transplants because of primary pulmonary hypertension.